ARCHIVES

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 44 | November 17, 1989

Download PDF Visit The Full Archive

Related Articles

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002